A new HPLC approach for the determination of hydrophilic and hydrophobic components: The case of pseudoephedrine sulfate and loratadine in tablets

Drug Development and Industrial Pharmacy

Volumn 31, Issue 6, 2005, Pages 577-588

  Abu Lathou, Ali ^a   Hamdan, Imad I ^a   Tahraoui, Ahmed ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b ProPharma Ltd   (United Kingdom)

Author keywords

Combination stationary phase; HPLC; Loratadine; Pseudoephedrine

Indexed keywords

ANTIHISTAMINIC AGENT; CHLORPHENIRAMINE; CLARITIN D; DECONGESTIVE AGENT; DESLORATADINE; DODECYL SULFATE SODIUM; LORATADINE; MEPHENTERMINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; TRIPROLIDINE;

ARTICLE; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; PHASE SEPARATION; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; TIME;

ACETATES; BUFFERS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPHEDRINE; HYDROGEN-ION CONCENTRATION; HYDROPHOBICITY; LORATADINE; REPRODUCIBILITY OF RESULTS; SODIUM DODECYL SULFATE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 24644517952     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500214696     Document Type: Article

References (35)

1. Argekar, A. P., Shah, S. J., & Raj, S. V. (1998). Drug Development and Industrial Pharmacy, 24, 219-223.
2. Brendel, E., Meineke, I., Henne, E. M., Zschunke, M., & De Mey, C. (1988). Journal of Chromatography, 426, 406-411.
3. Bronsky, E., Boggs, P., Findlay, S., Gawchik, S., Georgitis, J., Mansmann, H., Sholler, L., Wolfe, J., Meltzer, E., & Morris, R. (1995). Journal of Allergy and Clinical Immunology, 96, 139-147.
4. Bye, C., Hill, H. M., Hughes, D. T. D., & Peck, A. W. (1975). Journal of Clinical Pharmacology, 8, 47-53.
5. Carnevale, L. (1983). Journal of Pharmaceutical Sciences, 72, 196-198.
6. Chao, M. K., Holcomb, I. J., & Fusari, S. A. (1979). Journal of Pharmaceutical Sciences, 68, 1463-1474.
7. Davidson, A. G., & El-Sheikh, H. (1982). Analyst, 107, 879-884.
8. El-Ragehy, N. A., Badawy, A. M., & Khateeb, S. Z. (2002). Journal of Pharmaceutical and Biomedical Analysis, 28, 1041-1053.
9. Georgitis, J. W., Meltzer, E. O., Kaliner, M., Weiler, J., & Berkowitz, R. (2000). Annals of Allergy, Asthma, & Immunology, 84, 451 -459.
10. Ghoneim, M. M., Mabrouk, M. M., Hassanein, A. M., & Tawfik, A. (2001). Journal of Pharmaceutical and Biomedical Analysis, 25, 933-939.
11. Gil-Agusti, M., Capella-Peiro, M. E., Monferrer-Pons, L., Garcia-Alvarez-Coque, M. C., & Esteve-Romero, J. (2001). Analyst, 126, 457-464.
12. Hood, D. J., & Cheung, H. Y. (2003). Journal of Pharmaceutical and Biomedical Analysis, 30, 1595-1601.
13. Hoover, J. M., Sottero, R. A., & Bansal, P. C. (1987). Journal of Pharmaceutical Sciences, 76, 242-244.
14. (1994). ICH Guidelines: Validation of Analytical Procedures: Q2A.
15. (1996). ICH Guidelines: Validation of Analytical Procedures: Q2B.
16. Ivanovic, D., Medenica, M., Markovic, S., & Mandic, G. (2000). Arzneimittel-Forschung, 50, 1004-1008.
17. Johnson, R., Christensen, J., & Lin, C. C. (1994). Journal of Chromatography, B, Biomedical Sciences and Applications, 657, 125-131.
18. Kay, G. G., & Harris, A. G. (1999). Clinical & Experimental Allergy, 29, 147-150.
19. Kord, A. S. & Khaledi, M. G. (1992). Analytical Chemistry, 64, 1901-1907.
20. Kunicki, P. K. (2001). Journal of Chromatography, B, Biomedical Sciences and Applications, 755, 331-335.
21. Lai, C. M., Stoll, R. G., Look, Z. M., & Yacobi, A. (1979). Journal of Pharmaceutical Sciences, 68, 1243-1246.
22. Mabrouk, M. M., El-Fatatry, H. M., Hammad, S., & Wahbi, A. A. M. (2003). Journal of Pharmaceutical and Biomedical Analysis, 33, 597-604.
23. Macek, J., Ptaek, P., & Klima, J. (2002). Journal of Chromatography, B, Analytical Technology and Biomedical Life Science, 25, 289-294.
24. Makhija, S. N., & Vavia, P. R. (2001). Journal of Pharmaceutical and Biomedical Analysis, 25, 663-667.
25. Ragonese, R., Mulholland, M., & Kalman, J. (2000). Journal of Chromatography, A, 870, 45-51.
26. Roman, I. J., & Danzig, M. R. (1993). Clinical Reviews in Allergy, 11, 89-110.
27. Ruperez, F. J., Fernandez, H., & Barbas, C. (2002). Journal of Pharmaceutical and Biomedical Analysis, 29, 35-41.
28. Sagara, K., Oshima, T., & Misaki, T. (1983). Chemical and Pharmaceutical Bulletin, 31, 2359-2365.
29. Serra, H. A., Alves, O., Rizzo, L. F., Devoto, F. M., & Ascierto, H. (1998). British Journal of Clinical Pharmacology, 45, 147-150.
30. Smith, M. B., & Feldman, W. (1993). JAMA, 269, 2258-2263.
31. Snyder, L. R., Kirkland, J. J., Joseph, L., Glajch, J. L. (Eds.). (1997). Practical HPLC Method Development. New York: John Wiley & Sons.
32. Spyridaki, M. H., Tsitsimpikou, C. J., Siskos, P. A., & Georgakopoulos, C. G. (2001). Journal of Chromatography, B, Biomedical Sciences and Applications, 758, 311 -314.
33. Sutherland, F. C. W., de Jager, A. D., Badenhorst, D., Scanes, T., Hundt, H. K. L., Swart, K. J., & Hundt, A. F. (2001). Journal of Chromatography, A, 914, 37-43.
34. Till, A. E., & Benet, L. Z. (1979). Pharmacology, 18, 306-310.
35. Weinstein, S. F. (2002). Allergy and Asthma Proceedings, 23, 1-3.